Skip to main content

Discussion of Reducing the Risk of Cancer in Life and Health Insurance

  • Chapter
  • First Online:
Life Insurance in Europe

Part of the book series: Financial and Monetary Policy Studies ((FMPS,volume 50))

  • 431 Accesses

Abstract

The dynamics of the increase in illnesses, including oncological diseases, causes a different view on the scope of insurance protection offered by insurance companies. The way to limit the risks inherent in life insurance should not just be to add inclusions to offers. It is possible for insurance companies to focus on other activities that may not only reduce the consequences of liability for specific risks but also improve the offer and product sales. The purpose of the chapter is to demonstrate the increasing risk of cancer in life insurance and its consequences. The study contains not only to analyse examples of designs of health insurance products with the option of insurance against cancer, the so-called “cancer cover type health insurance”, but also to demonstrate the benefits of supplementing insurance products with additional elements to reduce the potential effects of negative events. Presentation of the experiences of one country (Poland) in this respect should become the opening for a debate on the form of offers constructed by insurance companies in different countries, which could be beneficial for economic and social security of the insured.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ambroggi M. (et al.), 2015, Distance as a barrier to cancer diagnosis and treatment: Review of literature, The Oncologist, 20, 12, 1379–1383

    Google Scholar 

  • Biuletyn statystyczny Ministerstwa Zdrowia, Centrum Systemów Informacyjnych Ochrony Zdrowia 2019.

    Google Scholar 

  • Caplan, G. (1964). Principles of prevention psychiatry. New York: Basic Books.

    Google Scholar 

  • Diagnostic services in oncology. The problem of scarce re-sources. Economic and Environmental Studies, www.ees.uni.opole.pl. ISSN paper version 1642–2597, ISSN electronic version 2081–8319.

    Google Scholar 

  • Dostęp pacjentów onkologicznych do terapii lekowych w Polsce na tle aktualnej wiedzy medycznej, Raport 2017, ALIVA Fundacja Onkologiczna 2017.

    Google Scholar 

  • Fundacji im. L. Pagi. (2019). Pokłady cyfrowego bogactwa w służbie pacjentom, czyli o wykorzystaniu potencjału danych w sektorze ochrony zdrowia, Raport Alumnów projektu „Liderzy ochrony zdrowia”.

    Google Scholar 

  • https://axa.pl/pomoc-na-raka/ (2017).

    Google Scholar 

  • https://www.nn.pl/rakowi-wspak (2017).

    Google Scholar 

  • Metodyka pomiaru kosztów pośrednich w polskim systemie ochrony zdrowia, Raport EY, Program EY Sprawne Państwo, 2013.

    Google Scholar 

  • OECD/EU. (2016). Health at a glance: Europe 2016. State of health in the EU cycle. Paris: OECD.

    Google Scholar 

  • Poprawa efektywności i stabilności opieki onkologicznej. Rekomendacje dla Polski, Raport inicjatywy All. Can., 2017.

    Google Scholar 

  • Ruszkowski, J., & Leśniowska, J. (2010). Rzeczywiste, ekonomiczne koszty choroby w Polsce. http://www.pszw.edu.pl/images/publikacje/t025_pszw_2010_ruszkowski_lesniowska_-_rzeczywiste_ekonomiczne_koszty_choroby_w_polsce.pdf.

  • Sowada, C., Sagan, A., & Kowalska-Bobko, I. (2019). Poland: Health system review. Health Systems in Transition, 21(1), 1–234.

    Google Scholar 

  • Systemy opieki onkologicznej w wybranych państwach, Raport EY, Program EY Sprawne Państwo, 2014.

    Google Scholar 

  • World Cancer Report. (2008). Peter Boyle and Bernard Levin, IARC, Lyon

    Google Scholar 

  • www.mpz.mz.gov.pl.

    Google Scholar 

  • www.piu.org.pl.

    Google Scholar 

  • Zawadzki, P. (2017). Wpływ badań przesiewowych w zakresie badań raka piersi na poprawę efektywności finansowej systemu opieki medycznej w Polsce. Nauki Zarządzaniu Management Sciences, 3(32).

    Google Scholar 

  • Zdrowie i ochrona zdrowia w 2017r Health and healthcare in 2017, Analizy statystyczne GUS

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Węgrzyn .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Węgrzyn, M. (2020). Discussion of Reducing the Risk of Cancer in Life and Health Insurance. In: Borda, M., Grima, S., Kwiecień, I. (eds) Life Insurance in Europe. Financial and Monetary Policy Studies, vol 50. Springer, Cham. https://doi.org/10.1007/978-3-030-49655-5_13

Download citation

Publish with us

Policies and ethics